Bessemer Group’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-224,102
Closed -$2.22M 1841
2022
Q3
$2.22M Buy
+224,102
New +$2.22M 0.01% 427